Metabolite Variations in the Hippocampus and Corpus Callosum of Patients with Mild Cognitive Impairment Using Magnetic Resonance Spectroscopy with Three-Dimensional Chemical Shift Images

This study compared the metabolites in the brain regions of hippocampus and corpus callosum between patients with mild cognitive impairment (MCI) and healthy controls using no-radiation and high-sensitivity magnetic resonance spectroscopy (MRS) with three-dimensional chemical shift images (3D-CSI)....

Full description

Bibliographic Details
Main Authors: Yen-Lon Kau, I-Hung Lin, Chi-Long Juang, Chao-Kai Chang, Wen-Hsiang Ho, Hsiao-Chuan Wen
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/13/9/1244
_version_ 1797581048372002816
author Yen-Lon Kau
I-Hung Lin
Chi-Long Juang
Chao-Kai Chang
Wen-Hsiang Ho
Hsiao-Chuan Wen
author_facet Yen-Lon Kau
I-Hung Lin
Chi-Long Juang
Chao-Kai Chang
Wen-Hsiang Ho
Hsiao-Chuan Wen
author_sort Yen-Lon Kau
collection DOAJ
description This study compared the metabolites in the brain regions of hippocampus and corpus callosum between patients with mild cognitive impairment (MCI) and healthy controls using no-radiation and high-sensitivity magnetic resonance spectroscopy (MRS) with three-dimensional chemical shift images (3D-CSI). Twenty volunteers (seven patients with MCI and 13 healthy controls) aged 50–71 years were recruited for this prospective study. MRS with 3D-CSI images of a variety of metabolites was collected from the hippocampus and corpus callosum. Sex and weight showed no significant differences between the two groups. The metabolite levels in the hippocampus and corpus callosum of the MCI group were generally lower than in those of the healthy group, especially for creatine (<i>p</i> < 0.001 in the hippocampus and <i>p</i> = 0.020 in the corpus callosum) and N-acetyl aspartate/creatine (<i>p</i> < 0.001 in the hippocampus and <i>p</i> = 0.020 in the corpus callosum); however, choline/creatine showed a significant difference (<i>p</i> < 0.001) only in the hippocampus, and myo-inositol/creatine showed a significant difference (<i>p</i> < 0.001) only in the corpus callosum. Our study demonstrated that MRS with 3D-CSI can be used to measure these metabolite levels to determine the differences between patients with MCI and healthy individuals. This would aid early diagnosis of MCI in clinical practice, and patients could receive prompt intervention to improve their quality of life.
first_indexed 2024-03-10T22:59:37Z
format Article
id doaj.art-ad28ca077bc04f19991ac821d1d42f1c
institution Directory Open Access Journal
issn 2076-3425
language English
last_indexed 2024-03-10T22:59:37Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj.art-ad28ca077bc04f19991ac821d1d42f1c2023-11-19T09:48:16ZengMDPI AGBrain Sciences2076-34252023-08-01139124410.3390/brainsci13091244Metabolite Variations in the Hippocampus and Corpus Callosum of Patients with Mild Cognitive Impairment Using Magnetic Resonance Spectroscopy with Three-Dimensional Chemical Shift ImagesYen-Lon Kau0I-Hung Lin1Chi-Long Juang2Chao-Kai Chang3Wen-Hsiang Ho4Hsiao-Chuan Wen5Department of Medical Imaging, Camillian St. Mary’s Hospital, Luodong, Yilan 265502, TaiwanNobel Eye Institute, Taipei 100008, TaiwanDepartment of Medical Imaging and Radiological Sciences, Yuanpei University, Hsinchu 30015, TaiwanNobel Eye Institute, Taipei 100008, TaiwanDepartment of Medical Imaging, Camillian St. Mary’s Hospital, Luodong, Yilan 265502, TaiwanDepartment of Pet Healthcare, Yuanpei University, Hsinchu 300, TaiwanThis study compared the metabolites in the brain regions of hippocampus and corpus callosum between patients with mild cognitive impairment (MCI) and healthy controls using no-radiation and high-sensitivity magnetic resonance spectroscopy (MRS) with three-dimensional chemical shift images (3D-CSI). Twenty volunteers (seven patients with MCI and 13 healthy controls) aged 50–71 years were recruited for this prospective study. MRS with 3D-CSI images of a variety of metabolites was collected from the hippocampus and corpus callosum. Sex and weight showed no significant differences between the two groups. The metabolite levels in the hippocampus and corpus callosum of the MCI group were generally lower than in those of the healthy group, especially for creatine (<i>p</i> < 0.001 in the hippocampus and <i>p</i> = 0.020 in the corpus callosum) and N-acetyl aspartate/creatine (<i>p</i> < 0.001 in the hippocampus and <i>p</i> = 0.020 in the corpus callosum); however, choline/creatine showed a significant difference (<i>p</i> < 0.001) only in the hippocampus, and myo-inositol/creatine showed a significant difference (<i>p</i> < 0.001) only in the corpus callosum. Our study demonstrated that MRS with 3D-CSI can be used to measure these metabolite levels to determine the differences between patients with MCI and healthy individuals. This would aid early diagnosis of MCI in clinical practice, and patients could receive prompt intervention to improve their quality of life.https://www.mdpi.com/2076-3425/13/9/1244mild cognitive impairmentmagnetic resonance imagingmagnetic resonance spectroscopyhippocampal gyruscorpus callosum
spellingShingle Yen-Lon Kau
I-Hung Lin
Chi-Long Juang
Chao-Kai Chang
Wen-Hsiang Ho
Hsiao-Chuan Wen
Metabolite Variations in the Hippocampus and Corpus Callosum of Patients with Mild Cognitive Impairment Using Magnetic Resonance Spectroscopy with Three-Dimensional Chemical Shift Images
Brain Sciences
mild cognitive impairment
magnetic resonance imaging
magnetic resonance spectroscopy
hippocampal gyrus
corpus callosum
title Metabolite Variations in the Hippocampus and Corpus Callosum of Patients with Mild Cognitive Impairment Using Magnetic Resonance Spectroscopy with Three-Dimensional Chemical Shift Images
title_full Metabolite Variations in the Hippocampus and Corpus Callosum of Patients with Mild Cognitive Impairment Using Magnetic Resonance Spectroscopy with Three-Dimensional Chemical Shift Images
title_fullStr Metabolite Variations in the Hippocampus and Corpus Callosum of Patients with Mild Cognitive Impairment Using Magnetic Resonance Spectroscopy with Three-Dimensional Chemical Shift Images
title_full_unstemmed Metabolite Variations in the Hippocampus and Corpus Callosum of Patients with Mild Cognitive Impairment Using Magnetic Resonance Spectroscopy with Three-Dimensional Chemical Shift Images
title_short Metabolite Variations in the Hippocampus and Corpus Callosum of Patients with Mild Cognitive Impairment Using Magnetic Resonance Spectroscopy with Three-Dimensional Chemical Shift Images
title_sort metabolite variations in the hippocampus and corpus callosum of patients with mild cognitive impairment using magnetic resonance spectroscopy with three dimensional chemical shift images
topic mild cognitive impairment
magnetic resonance imaging
magnetic resonance spectroscopy
hippocampal gyrus
corpus callosum
url https://www.mdpi.com/2076-3425/13/9/1244
work_keys_str_mv AT yenlonkau metabolitevariationsinthehippocampusandcorpuscallosumofpatientswithmildcognitiveimpairmentusingmagneticresonancespectroscopywiththreedimensionalchemicalshiftimages
AT ihunglin metabolitevariationsinthehippocampusandcorpuscallosumofpatientswithmildcognitiveimpairmentusingmagneticresonancespectroscopywiththreedimensionalchemicalshiftimages
AT chilongjuang metabolitevariationsinthehippocampusandcorpuscallosumofpatientswithmildcognitiveimpairmentusingmagneticresonancespectroscopywiththreedimensionalchemicalshiftimages
AT chaokaichang metabolitevariationsinthehippocampusandcorpuscallosumofpatientswithmildcognitiveimpairmentusingmagneticresonancespectroscopywiththreedimensionalchemicalshiftimages
AT wenhsiangho metabolitevariationsinthehippocampusandcorpuscallosumofpatientswithmildcognitiveimpairmentusingmagneticresonancespectroscopywiththreedimensionalchemicalshiftimages
AT hsiaochuanwen metabolitevariationsinthehippocampusandcorpuscallosumofpatientswithmildcognitiveimpairmentusingmagneticresonancespectroscopywiththreedimensionalchemicalshiftimages